Opioid use in children with inflammatory bowel disease-related arthritis
- PMID: 37083174
- PMCID: PMC10523932
- DOI: 10.55563/clinexprheumatol/3bu1sf
Opioid use in children with inflammatory bowel disease-related arthritis
Abstract
Objectives: Concomitant arthritis may increase risk of chronic opioid use in youngsters with IBD. We aimed to assess trends and clinical features associated with opioid use in children with IBD-related arthritis.
Methods: Adolescents under 18 years of age with IBD-related arthritis, at least 1 year of continuous enrolment, and at least 1 pharmacy claim in the Truven Health MarketScan Claims and Encounter Database were included. Subjects were identified using previously validated algorithms consisting of ICD codes, pharmacy claims and procedure codes. The primary outcome was chronic opioid exposure. Temporal trends in opioid exposure were tested using the Cuzick-Wilcoxon test. The association of chronic opioid use and baseline covariates in the IBD and IBD-arthritis cohorts were examined using multivariable logistic regression models.
Results: 14,943 adolescents with IBD, 480 of whom had arthritis, were included. Chronic opioid use was non-trivial in youngsters with IBD-related arthritis, higher than that of total IBD cohort (12.3% vs. 5%) and remained stable over the years of study. Using multivariable regression, joint pain and arthritis were significantly associated with chronic opioid exposure in young people with IBD. Among IBD-related arthritis patients older age, public insurance, gastrointestinal surgery, hospitalisation and psychiatric comorbidities were significantly associated with chronic opioid use.
Conclusions: Chronic opioid use in adolescents with IBD-related arthritis was higher than that of total IBD cohort but stable over the years of study. Future study is needed to explore ways to optimise non-narcotic pain management strategies and ensuring appropriate use of opioids when necessary.
Figures


Similar articles
-
Impact of chronic opioid use on acute health care utilization in children with IBD and arthritis: a retrospective cohort study.BMC Pediatr. 2024 Nov 7;24(1):711. doi: 10.1186/s12887-024-05206-y. BMC Pediatr. 2024. PMID: 39511521 Free PMC article.
-
Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.Inflamm Bowel Dis. 2018 Sep 15;24(10):2093-2103. doi: 10.1093/ibd/izy222. Inflamm Bowel Dis. 2018. PMID: 29986015 Free PMC article.
-
Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population.Inflamm Bowel Dis. 2025 Feb 10;31(2):386-393. doi: 10.1093/ibd/izae188. Inflamm Bowel Dis. 2025. PMID: 39226051 Free PMC article.
-
Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.Inflamm Bowel Dis. 2019 Nov 14;25(12):1990-1995. doi: 10.1093/ibd/izz100. Inflamm Bowel Dis. 2019. PMID: 31087042
-
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.Inflamm Bowel Dis. 2022 Dec 1;28(12):1904-1914. doi: 10.1093/ibd/izac021. Inflamm Bowel Dis. 2022. PMID: 35230420 Free PMC article.
Cited by
-
Impact of chronic opioid use on acute health care utilization in children with IBD and arthritis: a retrospective cohort study.BMC Pediatr. 2024 Nov 7;24(1):711. doi: 10.1186/s12887-024-05206-y. BMC Pediatr. 2024. PMID: 39511521 Free PMC article.
References
-
- CROSS RK, WILSON KT, BINION DG. Narcotic use in patients with Crohn’s disease. Am J Gastroenterol. Oct 2005;100(10):2225–9. - PubMed
-
- EDWARDS JT, RADFORD-SMITH GL, FLORIN TH. Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. J Gastroenterol Hepatol. Nov 2001;16(11):1235–8. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical